IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v601y2022i7893d10.1038_d41586-022-00079-6.html
   My bibliography  Save this article

Omicron thwarts some of the world’s most-used COVID vaccines

Author

Listed:
  • Elie Dolgin

Abstract

Inactivated-virus vaccines elicit few, if any, infection-blocking antibodies — but might still protect against severe disease.

Suggested Citation

  • Elie Dolgin, 2022. "Omicron thwarts some of the world’s most-used COVID vaccines," Nature, Nature, vol. 601(7893), pages 311-311, January.
    • Handle: RePEc:nat:nature:v:601:y:2022:i:7893:d:10.1038_d41586-022-00079-6
    DOI: 10.1038/d41586-022-00079-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/d41586-022-00079-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/d41586-022-00079-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Suman Das & Janmejay Singh & Heena Shaman & Balwant Singh & Anbalagan Anantharaj & Patil Sharanabasava & Rajesh Pandey & Rakesh Lodha & Anil Kumar Pandey & Guruprasad R. Medigeshi, 2022. "Pre-existing antibody levels negatively correlate with antibody titers after a single dose of BBV152 vaccination," Nature Communications, Nature, vol. 13(1), pages 1-7, December.
    2. Otavio T. Ranzani & Matt D. T. Hitchings & Rosana Leite Melo & Giovanny V. A. França & Cássia de Fátima R. Fernandes & Margaret L. Lind & Mario Sergio Scaramuzzini Torres & Daniel Henrique Tsuha & Let, 2022. "Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil," Nature Communications, Nature, vol. 13(1), pages 1-10, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:601:y:2022:i:7893:d:10.1038_d41586-022-00079-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.